累计发表科研论文261篇,其中87篇被SCI收录。代表作如下:
1. Q. Yang, Y. Zhai, L Chen, T Zhang, Y. Yan, T. Meng, L. Liu, L. Chen, X. Wang, Y. Dong*. Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients. Acta Pharmacol Sin. 2018, 1(1): 1-11.
2. T. Wang, M. Yan, D. Tang, L. Xue, T. Zhang, Y. Dong, L. Zhu, X. Wang, Y. Dong*. Therapeutic Drug Monitoring and Safety of Voriconazole Therapy in Patients with Child-Pugh Class B and C Cirrhosis: A Multicenter Study. Int J Infect Dis. 2018, 72: 49-54.
3. S. Hu, T. Wang, H. You, S. Wei, H. Song, T. Zhang, D. Zhang, Y. Dong*. Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens. Basic & Clinical Pharmacology & Toxicology. 2018.
4. L. Chen, Y. Wang, T. Zhang, Y. Li, T. Meng, L. Liu, R. Hao, Y. Dong*. Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis. BMC Infect Dis. 2018, 18(1): 155.
5. T. Wang, T. Zhang, T. Meng, Y. Li, L. Chen, Q. Yang, Y. Dong, J. Lei, L. Chen, Y. Dong*. A Strategy for designing Voriconazole Dosage Regimens to Prevent Invasive Pulmonary Aspergillosis Based on a Cellular Pharmacokinetics /pharmacodynamics Model. Journal of Translational Medicine. 2018, 16(1): 157-166.
6. H. You, Y. Dong, Y. Zou, T. Zhang, J. Lei, L. Chen, X. Wang, Y. Dong*, T. Wang*. Voriconazole therapeutic drug monitoring: factors associated with supertherapeutic and subtherapeutic voriconazole concentrations. Int J Clin Pharmacol Ther. 2018, 56(5): 239-246.
7. Y. Zou, J. Lian, Y. Di, H. You, H. Yao, L. Liu, Y. Dong*. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units. Int J Clin Pharm. 2018, 40(1): 175-182.
8. Y. Wang, Y. Xing, L. Chen, T. Meng, Y. Li, J. Xie, L. Chen, Y. Dong*, W. Dong*. Fluconazole versus mould‑active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost‑efectiveness analysis. International Journal of Hematology. Int J Hematol. 2018, 107: 235-243.
9. Y. Wang, J. Xie, Y. Xing, L. Chen, Y. Li, T. Meng, W. Dong, X. Wang, Y. Dong*. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis. Antimicrobial Agents and Chemotherapy. 2017, 61(12): e00620-17.
10. T. Zhang, Y. Wang, Q. Yang, Y. Dong*. Procalcitonin-Guided Antibiotic Therapy in Critically Ill Adults: A Meta-analysis. BMC Infect Dis. 2017, 17(1): 514-525.
11. J. Xie, J. Roberts, A. Alobaid, C. Roger, Y. Wang, Q. Yang, J. Sun, H. Dong, X. Wang, X. Feng, J. Lipman, Y. Dong*. Population pharmacokinetics of tigecycline in critically ill patients with severe infections. Journal of Antimicrobial Chemotherapy. 2017, 61(8): 00345-17.
12. Y. Wang, Q. Yang, L. Chen, L. Liu, R. Hao, T. Zhang, X. Wang, J. Lei, J Xie, Y. Dong*. Cross-resistant of voriconazole and fluconazole non-albicans Candida infection in intensive care unit patients. European Journal of Clinical Microbiology & Infectious Diseases. 2017, 36(11): 2117-2126.
13. T. Wang, Q. Yang, Y. Li, T. Meng, Y. Wang, T. Zhang, J. Lei, J. Xing, Y. Dong*. Uptake and efflux kinetics, and intracellular activity of voriconazole against A. fumigatus in human pulmonary epithelial cells: a new challenge treating intracellular infection. Fundamental & Clinical Pharmacology. 2017, 31(3): 311-318.
14. T. Wang, Q. Yang, Y. Wang, Y. Li, T. Meng, L. Chen, J. Xie, J. Xing, Y. Dong*. Determination and Characterization of Uptake of Voriconazole in Human Lung Epithelial Cells by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Analytical letters. 2017, 50(2): 304-314.
15. H. Dong, J. Xie, T. Wang, L. Chen, X. Zeng, J. Sun, X. Wang, Y. Dong*. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients. International Journal of Antimicrobial Agents. 2016, 48: 259-264.
16. Y. Wang, T. Wang, J. Xie, Q. Yang, X. Zheng, W. Dong, J. Xing, X. Wang, Y. Dong*. Correlation between Voriconazole Trough Plasma Concentration or CYP2C19 Genotypes and Hepatotoxicity in Intensive Care Unit Patients. Pharmacotherapy. 2016, 36(7): 757-765.
17. Q. Yang, T. Wang, J. Xie, Y. Wang, X. Zheng, L. Chen, Y. Li, T. Meng, Y. Dong*. Pharmacokinetic/pharmacodynamic adequacy of echinocandinsagainst Candida spp. in intensive care unit patients and generalpatient populations. International Journal of Antimicrobial Agents. 2016, 479(5): 397-402.
18. Q. Yang, T. Wang, J. Xie, Y. Wang, X. Zheng, L. Chen, X. Cheng, H. Dong, W. Dong, X. Zeng, X. Wang, Y. Dong*. A sensitive ultra-performance liquid chromatography-tandem mass spectrometry method to monitor caspofungin trough plasma concentrations and association between troughs and efficacy in intensive care unit patients. RSC Advances. 2015, 5: 104806-104814.
19. X. Zheng, C. Wang, Y. Xing, S. Chen, T. Meng, H. You, I. Ojima*, Y. Dong*. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells. International Journal of Oncology. 2017, 50: 893-902.
20. J. Xie, Y. Wang, X. Zheng, Q. Yang, T. Wang, Y. Zou, J. Xing, Y. Dong*. Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital. American Journal of Infection Control. 2015, 43(8): 861-864.
21. T. Wang, J. Xie, Y. Wang, X. Zheng, J. Lei, X. Wang, H. Dong, Q. Yang, L. Chen, J. Xing, Y. Dong*. Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections. Pharmacotherapy. 2015, 35(9): 797-804.
22. T. Wang, N. Li, S. Hu, J. Xie, J. Lei, Y. Wang, X. Zheng, J. Xing, Y. Dong*. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections. International Journal of Clinical Pharmacology and Therapeutics. 2015, 53(5): 356-362.
23. Y. Zou, Y. Ma, J. Liu, J. Shi, T. Fan, Y. Shan, H. Yao, Y. Dong*. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). European Journal of Clinical Microbiology & Infectious Diseases. 2015, 34: 795-803.
24. Y. Wang, Y. Zou, J. Xie, T. Wang, X. Zheng, H. He, W. Dong, J. Xing, Y. Dong*. Linezolid versus Vancomycin for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: a systematic review with meta-analysis and cost-effectiveness analysis in China. European Journal of Clinical Pharmacology. 2015, 71: 107-115.
25. W. Zhang, J. Cai, S. Chen, X. Zheng, S. Hu, W. Dong, J. Lv, J. Xing, Y. Dong*. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway. Mol Med Rep. 2015, 12(1): 1506-1514.
26. J. Cai, S. Chen, W. Zhang, X. Zheng, S. Hu, C. Pang, J. Lv, J. Xing, Y. Dong*. Salvianolic acid A reverses paclitaxel resistance in human breast cancer cells via targeting the expression of transgelin 2 and attenuating PI3K/Akt pathway. Phytomedicine. 2014, 21(12): 1725-1732.
27. T. Wang, H. Zhu, J. Sun, X. Cheng, J. Xie, H. Dong, L. Chen, X. Wang, J. Xing, Y. Dong*. Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections. Int J Antimicrob Agents. 2014, 44(5): 436-442.
28. S. Chen, Q. Dong, S. Hu, J. Cai, W. Zhang, J. Sun, T. Wang, J. Xie, H. He, J. Xing, J. Lv, Y. Dong*. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells. Molecular Biosystems. 2014, 10(2): 294-303.
29. J. Xie, T. Wang, X. Wang, X. Cheng, H. Dong, Y. Wang, X. Zheng, L. Zhou, J. Xing, Y. Dong*. Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method. Journal of Separation Science. 2014, 37(12): 1396-1403.
30. J. Xie, T. Wang, X. Wang, X. Cheng, H. Dong, Y. Wang, X. Zheng, L. Zhou, J. Xing, Y. Dong*. Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method. Journal of Separation Science. 2014, 37(12): 1396-1403.